Researchers have attributed separate clusters of previously tracked malicious activity to a single group that has elevated ...
Phantom Taurus' modus operandi also stands out due to the use of custom-developed tools and techniques rarely observed in the ...
The FDA has rejected a biologics license application for apitegromab to treat spinal muscular atrophy, according to manufacturer Scholar Rock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback